Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study

Chisato Narita, Fumihiko Urabe, Wataru Fukuokaya, Kosuke Iwatani, Yu Imai, Keiji Yasue, Keiichiro Mori, Koichi Aikawa, Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yuta Yamada, Steffi Kar Kei Yuen, Jeremy Yuen‐Chun Teoh, Tatsuya Shimomura, Hiroki Yamada, Akira Furuta, Jun Miki, Takahiro KimuraClinical 2024 · DOI

BibTeX
@inproceedings{narita2024site,
  author = {Chisato Narita and Fumihiko Urabe and Wataru Fukuokaya and Kosuke Iwatani and Yu Imai and Keiji Yasue and Keiichiro Mori and Koichi Aikawa and Takafumi Yanagisawa and Shoji Kimura and Kojiro Tashiro and Shunsuke Tsuzuki and Yuta Yamada and Steffi Kar Kei Yuen and Jeremy Yuen‐Chun Teoh and Tatsuya Shimomura and Hiroki Yamada and Akira Furuta and Jun Miki and Takahiro Kimura},
  title = {{Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study}},
  booktitle = {Clinical},
  year = {2024},
  doi = {10.1016/j.clgc.2024.102082},
}

Loading related content...

Figure